论坛简介：
复旦大学第七届复旦大学光华青年学者论坛——放射医学分论坛由887700葡京线路检测(中国)有限公司承办。本论坛旨在为海内外优秀青年学者搭建学术交流平台，通过学术研讨会和人才洽谈会等形式，围绕国际学术前沿，探讨学科热点问题，促进学术交流与合作，为我校战略人才引进计划和“超级博士后”计划的实施汇聚全球英才。
放射医学分论坛定于2023年3月中下旬在887700葡京线路检测(中国)有限公司举办，采用线上线下相结合方式。论坛现正式开启网上报名，我们诚邀海内外优秀青年人才参会交流，共谋发展！
论坛详情可浏览
光华青年学者论坛网站：http://ghforum.fudan.edu.cn
放射医学研究所网站：http://irm.fudan.edu.cn。
Introduction to Forum
Fudan-Guanghua International Forum for Young Scholars aims to create communication platforms for global young talented scholars with various research fields to discuss radiation medicine research spotlights, resolving frontier academic problems and cooperating among distinct disciplines. The forum also offers a mature platform for exploring academic frontier and promoting the exchange and cooperation, which can greatly proceed the talent introduce plan and the “Super postdoc” program to attract the professional all over the world.
The sub-forum of radiation medicine will be scheduled to be held in the Institute of Radiation Medicine, Fudan University in the mid-late March of 2023, holding both online and offline. The forum is now officially opening for online application. We sincerely invite excellent young talents from domestic and abroad to take part in this forum and exchange ideas for further development.
Further Info:
http://ghforum.fudan.edu.cn
申请条件
一、青年人才：
1. 遵纪守法，思想品德端正，学风优良，遵守教师职业道德，热爱教学科研事业；
2. 年龄一般不超过38周岁；
3. 具有海内外知名大学博士学位；
4. 在放射医学、放射生物学、放射药学、核安全与辐射防护、辐射损伤救治等与放射医学相关研究领域取得重要成绩，且具有良好的学术发展潜力。
Applicants Requirements
1. Hold a Ph.D. in radiation medicine and related fields;
2. Have remarkable achievements and great potentials in specific research area;
3. Generally under 38 years old.
4. Have obtained important achievements in Radiation medicine, Radiobiology, Radiopharmacy, Nuclear safety and Radiation protection, Radiation injury treatment and so on, and have a potential in academic development.
二、超级博士后：
1. 遵纪守法，思想品德端正，学风优良，遵守教师职业道德，热爱教学科研事业；
2. 年龄一般不超过35周岁；
3. 即将获得博士学位或获得博士学位一般不超过3年；
4. 在放射医学、放射生物学、放射药学、核安全与辐射防护、辐射损伤救治等与放射医学相关研究领域科研成果突出。
Applicants Requirements
1. Hold a Ph.D. in radiation medicine and related fields;
2. Have remarkable achievements and great potentials in specific research area;
3. Generally under 35 years old.
4. Have made outstanding achievements in research fields of Radiation medicine，Radiobiology, Radiopharmacy, Nuclear safety and Radiation protection, and Radiation injury treatment, etc.
申请方式：申请者请于2023年3月10日前将个人详细简历（包括教育、工作经历，发表论文目录、代表性成果简介、未来研究工作设想等）及联系方式发送至：zjh551268@fudan.edu.cn。邮件主题请注明"光华论坛+研究方向+姓名"。对申请人进行资格审核后，我们将通过邮件向审核通过人员发送邀请函。
To apply
Please send your 1) Resume; 2) Representative papers; 3) Contact information in a single PDF file to zjh551268@fudan.edu.cn before 10 Mar. 2023. Qualified applicants will receive an official invitation letter via E-mail to participate in the Forum.
放射医学研究所简介
应国家核战略的需求，887700葡京线路检测(中国)有限公司（简称“放医所”）于1962年成立，其前身是上海市工业卫生研究所，上海第一医学院院长陈同生兼任首任所长。1985年改名为上海医科大学放射医学研究所，2000年改为现名。
经过几十年来几代放医人的不懈努力，开拓进取，放医所已经发展成为一家集放射医学、辐射防护、放射药学三大板块为一体的研究机构，致力于电离辐射损伤与防治、肿瘤放射生物学、肿瘤放疗增敏、放射诊疗的防护与质量控制、天然与人工放射性对人体与环境的影响评价和控制、放射性核素促排药物、新型放射性标记与诊断药物等方面的研究。近年来，承担多项国家重点研发计划重点专项、国家自然科学基金重点项目，研究成果丰硕，为国家培养了大量高水平专业人才。
放医所秉承“科研为主，服务并重”的发展理念，在开展科研工作的同时，还积极服务社会，先后取得了放射卫生技术服务甲级资质、放射性疾病诊断资质、放射性工作人员职业健康体检资质，开展核技术应用建设项目的放射防护评价、环境放射性和放射诊疗设备的质量控制检测、放射工作人员个人剂量监测和健康检查以及职业放射病诊断等工作。
放医所招收放射医学专业的学术型博士和硕士研究生，主要研究方向有放射生物学、放射肿瘤学、辐射防护与剂量学、放射药学和放射毒理学等，毕业生就业率一直保持100%。放医所积极参与有关国际组织工作和国际交流活动，多名专家现任国际放射防护委员会（ICRP）委员、国际空间研究委员会（COSPAR）成员等，并与美、英、日等多个国家的科研院所保持着密切合作关系。
In response to the requirement of national nuclear strategy, the Institute of Radiology Medicine (IRM) of Fudan University was established in 1962. Her legacy name was the Shanghai Institute of Industrial Hygiene. Chen Tongsheng, the president of Shanghai First Medical College, served as the first director concurrently. In 1985, she was renamed as the Institute of Radiation Medicine of Shanghai Medical University, and uses the current name since 2000.
After decades of unremitting efforts of several generations, IRM has developed into a research institution integrating radiation medicine, radiation protection and radiopharmacy, dedicates to the studies of radiation injury and prevention, tumor radiobiology and radiosensitization, radiation protection and quality control of radiodiagnosis and radiotherapy, evaluation of the effects of natural and artificial radiation on health and environment, radionuclide excretion promoting drugs, new radiolabeled diagnostic drugs, etc. In recent years, it has undertaken a number of the key projects of national key R&D plan and the key projects of the National Natural Science Foundation of China. IRM has achieved fruitful research results and cultivated a large number of high-level professionals for the country.
Adhering to the idea "Giving priority to scientific research and paying equal attention to service", IRM also actively serves the society. She has successfully obtained the Class-A qualification of the technical service for radiation hygiene, the qualification for diagnosis of radiation diseases, and the qualification for occupational health examination of radiation workers. She has carried out the safety and protection evaluation of the construction projects for radiation application, the quality control testing of the equipment for radiodiagnosis and radiotherapy, monitoring of environmental radiation and the personal dose, health examination of radiation workers, and the diagnosis of occupational radiation diseases.
IRM enrolls academic doctoral and postgraduate students majoring in radiation medicine. The main research fields are radiation biology, radiation oncology, radiation protection and dosimetry, radiation pharmacy, radiation toxicology, etc. The employment rate of graduates has been 100%. IRM has actively participated in the work of relevant international organizations and international academic exchanges, and maintains close scientific cooperation with the institutions in the United States, the United Kingdom, Japan and other countries. A few of experts in IRM currently serve as the committee member of the International Commission on Radiological Protection (ICRP) and the International Committee on Space Research (COSPAR).
